arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Agilent Technologies, Inc.

A Industrials Biotechnology: Laboratory Analytical Instruments
$173.89
▲ +0.5% Today
as of Oct 22, 16:45 ET
Last 30 days +18.45% Sep 14 → Oct 22
$144.32 $153.30 $162.28 $171.25 $180.23 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$177.50
High
$179.00
Low
$171.23
Volume
$3M
Avg Vol
$2M
Mkt Cap
$42.3B
P/E (TTM)
48.72
Beta
—
52w High
$179.00
52w Low
$108.35
Div Yield
—
Shares Out
$282M

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 4 ● 21 ▼ 0
Oct 20 · 11:00 GuruFocus.com neutral
29 ETFs Add to Agilent Technologies (A) on Oct. 16
Oct 14 · 11:11 MA Medical Device Network bullish
Agilent acquires Proscia in deal worth up to $270m
Oct 14 · 10:20 MT Newswires neutral
JPMorgan Adjusts Price Target on Agilent Technologies to $195 From $190
▸ Show all 25 press releases & news Free account →

A earnings at a glance

The options market is pricing a move of about ±4.1% after the report, a range of roughly $166.78 to $181.00 from today's $173.89. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±0.5% on average; after the most recent report on May 27, 2026 it moved +0.7%. That means options currently expect more movement than A has typically delivered. A beat the consensus EPS estimate in 3 of its last 3 reported quarters. Implied volatility is currently 35%. The share price of $173.89 sits near its 52-week high.

More Industrials stocks · All stocks · Earnings calendar

Overview

52-week range
$108
$179
93% of range
Avg surprise (last 3)
+3.7%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
35%
EM ±4.1% · $170 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.38$0.66$0.93$1.21$1.49 Actual $1.19Actual $1.02Actual $0.38Actual $1.18Actual $1.05Actual $0.97Actual $1.11Actual $1.31Est $1.26Actual $1.37Est $1.36Actual $1.07Actual $1.49Est $1.40Actual $1.28 JanAprJulJanAprJulJanApr/2025Jul/2025JanApr/2026Jul
Revenue vs Net Income Revenue Net income
$0$493M$986M$1.5B$2.0B Jan 25Apr 25Jul 25Jan 26Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 31, 2026Jul 2026 $1.28 — — — — financials
Wed May 27, 2026Apr/2026 $1.49 $1.40 +6.4% +13.7% +0.7% earnings
Sat Jan 31, 2026Jan 2026 $1.07 — — — — financials
Wed Aug 27, 2025Jul/2025 $1.37 $1.36 +0.7% — — earnings
Wed May 28, 2025Apr/2025 $1.31 $1.26 +4.0% — -0.3% earnings
Fri Jan 31, 2025Jan 2025 $1.11 — — — — financials
Wed Jul 31, 2024Jul 2024 $0.97 — — — — financials
Tue Apr 30, 2024Apr 2024 $1.05 — — — — financials
Wed Jan 31, 2024Jan 2024 $1.18 — — — — financials
Mon Jul 31, 2023Jul 2023 $0.38 — — — — financials
Sun Apr 30, 2023Apr 2023 $1.02 — — — — financials
Tue Jan 31, 2023Jan 2023 $1.19 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue$1.88B$1.83B$1.80B—$1.74B$1.67B$1.68B—
Cost of revenue$836M$845M$852M—$850M$802M$782M—
Gross profit————————
Operating income$444M$399M$353M—$360M$300M$376M—
Net income$362M$339M$305M—$336M$215M$318M—
EPS (diluted)$1.28$1.20$1.07—$1.18$0.75$1.11—

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Cash & equivalents$1.76B$1.81B$1.76B$1.79B$1.53B$1.49B$1.47B$1.33B
Inventory$1.12B$1.09B$1.06B$1.02B$1.01B$991M$997M$972M
Total current assets$4.69B$4.76B$4.62B$4.59B$4.25B$4.21B$4.11B$3.96B
Total assets$13.97B$13.06B$12.81B$12.73B$12.23B$12.16B$11.91B$11.85B
Long-term debt$3.65B$3.05B$3.05B$3.05B$3.35B$3.35B$3.35B—
Total liabilities$6.60B$5.94B$5.91B$5.99B$5.86B$6.02B$5.89B$5.95B
Total equity$7.36B$-202M$-184M$6.74B$6.37B$-280M$-381M$5.90B

Implied volatility — last 90 days

24%34%44%53%63% Jun 07 — IV 37% · EM ±5.2%Jun 08 — IV 34% · EM ±4.5%Jun 09 — IV 34% · EM ±4.3%Jun 10 — IV 39% · EM ±4.6%Jun 11 — IV 33% · EM ±3.7%Jun 12 — IV 31% · EM ±3.2%Jun 15 — IV 34% · EM ±2.5%Jun 16 — IV 43% · EM ±2.5%Jun 17 — IV 51% · EM ±2.1%Jun 19 — IV 31% · EM ±6.9%Jun 22 — IV 31% · EM ±6.4%Jun 23 — IV 31% · EM ±6.4%Jun 24 — IV 33% · EM ±6.7%Jun 25 — IV 31% · EM ±6.1%Jun 26 — IV 32% · EM ±6.0%Jun 29 — IV 32% · EM ±5.7%Jun 30 — IV 31% · EM ±5.3%Jul 01 — IV 30% · EM ±5.1%Jul 02 — IV 32% · EM ±5.2%Jul 03 — IV 33% · EM ±5.2%Jul 06 — IV 32% · EM ±4.5%Jul 07 — IV 33% · EM ±4.3%Jul 08 — IV 31% · EM ±3.9%Jul 09 — IV 30% · EM ±3.6%Jul 10 — IV 27% · EM ±3.0%Jul 13 — IV 35% · EM ±2.9%Jul 14 — IV 33% · EM ±2.4%Jul 15 — IV 46% · EM ±2.7%Jul 16 — IV 51% · EM ±2.1%Jul 20 — IV 33% · EM ±7.9%Jul 21 — IV 33% · EM ±7.7%Jul 22 — IV 33% · EM ±7.6%Jul 23 — IV 33% · EM ±7.4%Jul 24 — IV 32% · EM ±7.1%Jul 27 — IV 33% · EM ±7.0%Jul 28 — IV 33% · EM ±6.7%Jul 29 — IV 30% · EM ±6.1%Jul 30 — IV 30% · EM ±5.9%Jul 31 — IV 30% · EM ±5.8%Aug 03 — IV 33% · EM ±5.8%Aug 04 — IV 31% · EM ±5.4%Aug 05 — IV 34% · EM ±5.6%Aug 06 — IV 32% · EM ±5.3%Aug 07 — IV 29% · EM ±4.6%Aug 10 — IV 27% · EM ±3.8%Aug 11 — IV 31% · EM ±4.1%Aug 12 — IV 30% · EM ±3.8%Aug 13 — IV 26% · EM ±3.0%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 42% · EM ±2.5%Aug 20 — IV 64% · EM ±2.7%Aug 24 — IV 44% · EM ±9.2%Aug 25 — IV 43% · EM ±8.9%Aug 26 — IV 44% · EM ±8.9%Aug 27 — IV 29% · EM ±5.6%Aug 28 — IV 27% · EM ±5.1%Aug 31 — IV 28% · EM ±5.0%Sep 01 — IV 27% · EM ±4.6%Sep 02 — IV 25% · EM ±4.1%Sep 03 — IV 26% · EM ±4.3%Sep 04 — IV 28% · EM ±4.3%Sep 07 — IV 31% · EM ±4.3%Sep 08 — IV 34% · EM ±4.5%Sep 09 — IV 32% · EM ±4.0%Sep 10 — IV 33% · EM ±3.9%Sep 11 — IV 30% · EM ±3.4%Sep 14 — IV 37% · EM ±3.1%Sep 15 — IV 33% · EM ±2.4%Sep 16 — IV 38% · EM ±2.2%Sep 17 — IV 60% · EM ±2.5%Sep 21 — IV 31% · EM ±6.5%Sep 22 — IV 30% · EM ±6.0%Sep 23 — IV 30% · EM ±6.0%Sep 24 — IV 32% · EM ±6.3%Sep 25 — IV 30% · EM ±5.8%Sep 28 — IV 34% · EM ±6.1%Sep 29 — IV 32% · EM ±5.5%Sep 30 — IV 32% · EM ±5.4%Oct 01 — IV 31% · EM ±5.0%Oct 02 — IV 28% · EM ±4.4%Oct 06 — IV 32% · EM ±4.2%Oct 07 — IV 32% · EM ±4.1%Oct 08 — IV 35% · EM ±4.1%

Sector peers

WAT
Waters Corporation
$42.8B $455.59+2.9%
MTD
Mettler-Toledo International, Inc.
$30.7B $1,684.64+3.1%
RVTY
Revvity, Inc.
$17.1B $157.36+0.9%
AVTR
Avantor, Inc.
$10.4B $17.15+3.2%
TXG
10x Genomics, Inc.
$9.9B $69.75-2.4%
BIO
Bio-Rad Laboratories, Inc.
$9.8B $363.50+2.5%

A earnings FAQ

What is A's expected move for earnings?

Options currently price a move of about ±4.1%, or $7.11 per share either way from $173.89.

How does A stock usually react to earnings?

Across the last 2 reports the average next-day move was ±0.5%, up 1 times and down 1 times.

What is A's implied volatility?

A's at-the-money implied volatility is about 35% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in